Category Archives: Health Care

BD Reaffirms Its Commitment to Advancing Patient Safety on World Patient Safety Day

BD Reaffirms Its Commitment to Advancing Patient Safety on World Patient Safety Day

BD Champions Patient Safety as a Cornerstone of Healthcare Excellence in MENAT on World Patient Safety Day 2023

Dubai, United Arab Emirates, September 17, 2023 – The Dubai branch of BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology organization builds upon its ongoing mission to create a resilient and sustainable healthcare ecosystem across the MENAT (Middle East, North Africa, and Turkey) region by commemorating World Patient Safety Day 2023. Observed worldwide on September 17th, World Patient Safety Day casts a spotlight on the imperative of patient safety and underscores BD’s unwavering commitment to elevating patient outcomes.

Continue reading BD Reaffirms Its Commitment to Advancing Patient Safety on World Patient Safety Day

Dr.Sahar Hashmi, expert in AI in healthcare, Business and Technologies, shares insights at the IHC held in Switzerland in Sep 2023

Dr. Sahar Hashmi, MD-PhDCEO of Myriad Consulting LLC, has expertise in AI in healthcare, digital health, data science, and AI business, with a special emphasis on generative AI applications. 

Dr. Hashmi served as a faculty member at Harvard University, teaching a graduate-level course on “Technology Integrations and Innovations in AI Applications.” This course also discussed the business aspects of AI applications and included predictions about OpenAI’s ChatGPT launch well before it emerged as a competitor to Google search last year in November 2022. 

Dr.Hashmi contributes prominently to the prestigious Entrepreneur magazine in the US on topics related to generative AI applications in enterprises and the roles big tech giants play in healthcare and AI in healthcare generally. https://www.entrepreneur.com/author/sahar-hashmi

Continue reading Dr.Sahar Hashmi, expert in AI in healthcare, Business and Technologies, shares insights at the IHC held in Switzerland in Sep 2023

RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

Exercise is akin to medicine in the treatment of diabetes. 30 minutes of exercise can reduce the risk of diabetes by 40%

Safety precautions and Exercise protocols for Diabetics were explained during the session

Session advised on being vigilant about the warning signs such as extreme fatigue, pain, dizziness, palpitations, fever, chest pain, or irregular heartbeat when performing exercises.

Wearing a diabetes identification bracelet is encouraged to ensure prompt medical attention in case of emergencies.

Continue reading RAK Hospital Webinar Unlocks the Power of Exercise in Diabetes Management

AbbVie to launch epcoritamab in the United Arab Emirates

New hope for non-Hodgkins lymphoma patients AbbVie to launch epcoritamab in the United Arab Emirates

 UAE is the first country after the country of origin (US) to be granted conditional regulatory approval

Dubai, United Arab Emirates, Sep. 12, 2023

TEPKINLY™ (epcoritamab) has received conditional regulatory approval in the United Arab Emirates (UAE) on August 15th 2023, being the first country after the country of origin (United States) to grant conditional regulatory approval. This milestone marks a significant step forward in the field of oncology and offers new hope for patients. TEPKINLY™ (epcoritamab) is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.

TEPKINLY™ (epcoritamab) is the First and Only Subcutaneous Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL).6

Continue reading AbbVie to launch epcoritamab in the United Arab Emirates

New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines

New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines, says Cleveland Clinic Expert

Development of migraine-specific drugs to prevent and relieve the debilitating condition are proving highly effective, says a headache specialist

September 7, 2023, CLEVELAND: Medications developed over the past few years to treat migraines are significantly improving the quality of life for those with the debilitating condition, according to an expert from global health system Cleveland Clinic.

“Before 2018, when the FDA-approved the first calcitonin gene-related peptide (CGRP) inhibitor to prevent migraines, we had to rely on medications originally designed to treat other diseases, says Emad Estemalik MD, MBA, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute. “Today, however, there are several CGRP inhibitors available that have been developed to prevent or to relieve the symptoms of migraines specifically.”

Continue reading New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines